Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-13IRON144JOHN QUISEL plan to sell securities of Disc Medicine, Inc. under Form 144MEDIUM
JOHN QUISEL filed Form 144 to notify SEC of plan to sell 33000 units of Disc Medicine, Inc. securities around 2026-07-13, with aggregate market value of $2,527,470.00. The total outstanding units is 38199089.0. The amount planned to be sold represents 0.09% of total outstanding units; Recent transactions in past 3 mont...
Mid CapBiotechnology
2026-07-13MLYS144Rodman David Malcom plan to sell securities of Mineralys Therapeutics, Inc. under Form 144MEDIUM
Rodman David Malcom filed Form 144 to notify SEC of plan to sell 14508 units of Mineralys Therapeutics, Inc. securities around 2026-07-13, with aggregate market value of $387,716.51. The total outstanding units is 82498101.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions...
Mid CapBiotechnology
2026-07-13MGNX144Thomas Spitznagel plan to sell securities of MACROGENICS, INC. under Form 144MEDIUM
Thomas Spitznagel filed Form 144 to notify SEC of plan to sell 17000 units of MACROGENICS, INC. securities around 2026-07-13, with aggregate market value of $75,529.00. The total outstanding units is 63563123.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Micro CapBiotechnology
2026-07-13ANAB144JOE ANTHONY WARE plan to sell securities of ANAPTYSBIO, INC. under Form 144MEDIUM
JOE ANTHONY WARE filed Form 144 to notify SEC of plan to sell 10694 units of ANAPTYSBIO, INC. securities around 2026-07-13, with aggregate market value of $718,333.09. The total outstanding units is 29100902.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transactions in past 3 mont...
Small CapBiotechnology